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Research Institute for Genetics and Immunological Grounds of Pathology and  Pharmacogenetics of Higher State Educational Estab-
lishment of Ukraine “Ukrainian Medical Stomatological Academy”, Poltava, Ukraine  
Surveyed individuals of both sexes aged 18-25 years, were divided into two groups according to body mass index (BMI), 
41 people - with normal weight (BMI 18,5-24,9 kg/m2) and - 27 with the overweight (BMI above 25 kg/m2). Indicators of 
total cholesterol, triglycerides, HDL and LDL cholesterol, glucose, insulin, insulin resistance index HOMA-IR have been 
studied. The level of chronic systemic inflammation was determined by the level of tumor necrosis factor-alpha and 
ceruloplasmin (CP). We determined the levels of neuropeptides - Agouti-related protein - AgRP and cocaine- and am-
phetamine-regulated transcript - CART. In the group of people with overweight were significantly increased insulin levels 
by 47,38%, HOMA-IR index by 44,02%, the CP by 10,98%, AgRP neuropeptides by 62,72%. It is suggested that under 
the conditions of excess uptake of nutrients, the formation of hyperinsulinemia and insulin resistance insulin contributes 
to increased  of AgRP neuropeptide secretion and early formation of pathological range. 
Keywords: overweight, chronic systemic inflammation, neuropeptides, energy metabolism.  
High-calorie foods with a much larger share of fats 
and carbohydrates, violations of diet, insufficient, to the 
amount of eaten food, level of physical activity are key 
factors for the obesity in the members of modern society. 
Changing the value of food, when their energy value be-
gins to dominate on the relaxing and social ones, con-
tributes to an overeating and steady growth of body 
weight [26].  
The abnormal growth of prevalence of the weight gain 
and obesity in the world requires a more careful attention 
from the medical and scientific community and social in-
stitutions. In particular, a well-founded connection be-
tween an overweight and such diseases as type 2 diabe-
tes, hypertension, osteoarthritis should cause concern 
[11].   
Currently, it is considered that the accumulation of lip-
ids in the adipose tissue is interfaced to a chronic in-
flammatory process of low intensity, which is a systemic 
process, not connected with an infectious one [28]; but it 
is one that promotes the violation of mechanisms of regu-
lation of energy homeostasis and leads to the dyslipide-
mia, atherosclerotic lesion of arteries, and endothelial 
dysfunction.  
It has been suggested that the development of in-
flammation in the adipose tissue may be the regulatory 
signal of local level and the systemic one as well - for en-
ergy metabolism, particularly, for the energy expenditures 
[3]. 
With obesity, exactly the adipose tissue is a major 
source of chronic inflammation [27]. The increase of the 
adipose tissue mass leads to the local response to hy-
poxia [14], which is the basis of a stress response of the 
adipose tissue in the form of oxidative stress, endoplas-
mic reticulum stress and inflammatory stress.  
An activation of nuclear transcription factor NF-κB 
happens in the adipocytes and macrophages of persons 
with an obesity under the hypoxic conditions by an alter-
native mechanism for ensuring thus the development of 
chronic inflammation in the adipose tissue [14].  
In general, the development and existence of the 
chronic systemic inflammation is a pathogenetic basis for 
creating a number of somatic diseases in the future. The 
development of obesity with the following manifestations 
of the chronic inflammation in the young age is even 
more threatening because of the loss of working capacity 
and its possible loss during the working age. Thus, the 
purpose of our study was to determine the mechanisms 
of formation and development of overweight in the young 
people.  
Materials and methods  
Order to solve this goal, we conducted a study involv-
ing 68 people of both sexes, aged 18-25 years. We got a 
permission for the study from a Commission on Bioethics 
of Higher State Educational Establishment of Ukraine 
“Ukrainian Medical Stomatological Academy”. We re-
ceived a voluntary consent from all participants before 
the test to take part in the research.  
We have been conducted the anthropometric studies 
to define the body weight, height, waist girth (WG), hip 
girth (HG), their ratio, to calculate the body mass index 
(BMI, WHO, 1998). According to BMI, we formed two 
groups. The control group consisted of 41 persons (20 
males and 21 females) with the normal weight (BMI 18,5-
24,9 kg/m2), the main group consisted of 27 persons, (16 
males and 11 females) with the overweight (BMI above 
25 kg/m2).  
Blood for the laboratory tests was given in the morn-
ing on an empty stomach from the cubital vein to the 
vacutainers (“Becton Dickinson”, USA). Lipid metabolism 
was evaluated by determining the level of total choles-
terol (CL), triglycerides (TG), HDL cholesterol (HDL CL) 
in the blood serum using test system (“Diakon DS”, Rus-
sia), and LDL cholesterol (LDL CL, «LaChema», Czech 
Republic).  
Carbohydrate metabolism was evaluated over the 
concentration of glucose (“Diakon DS”, Russia) and insu-
lin in the blood serum (“DRG”, Germany). The HOMA-IR 
(Homeostasis Model Assessment of Insulin Resistance) 
index was calculated by the formula: HOMA-IR = glucose 
on an empty stomach (mmol/l) × insulin on an empty 
stomach (mcU/ml) / 22,5 [16]. The presence of a chronic 
systemic inflammation was determined by the level of 
tumor necrosis factor-alpha (TNF-α) by ELISA (“Вектор-
Бест”, Russia) and by the level of ceruloplasmin (CP) us-
ing “Реагент” (Ukraine).  
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The level of neuropeptides of Agouti-related protein 
(AgRP) (“Cloud-Clone Corp”, USA) and cocaine- and 
amphetamine-regulated transcript (CART), (“RayBio-
tech”, USA) in the blood serum was investigated by 
ELISA using StatFax 303 Plus analyzer. 
Statistical analysis of data was performed using STA-
TISTICA 6.1 software package (StatSoft Inc, USA). The 
arithmetic average (M) and its error (m) was calculated 
accordingly. The correlation relationship of parameters 
were determined by the Spearman's rank correlation co-
efficient. Statistical significance was calculated by the 
Mann-Whitney criteria; the differences was considered as 
statistically significant when the probability of error was 
p<0,05.  
Results and discussion 
As shown by the studies, the anthropometric indica-
tors of young people with the overweight are significantly 
different from the indicators of people with the normal 
weight. It was determined the probable differences of 
mass and BMI of people with the overweight from the in-
dicators of people from the control group by 34% and 
34,5%, respectively (Table 1).  
Table 1  
Anthropometric indices of people from the surveyed groups (М±m, lower and upper quartiles)  
Parameters People with the normal weight n=41 
People with the overweight 
 n=27 
Age, 
years 
18,87 ± 0,17 
(18,0; 19,0) 
19,52 ± 0,44 
(18,0; 20,0) 
Height, 
cm 
173,80 ± 0,96 
(170,0; 179,0) 
173,59 ± 2,08 
(168,0; 181,0) 
Body mass, 
kg 
64,39 ± 1,05 
(58,0; 70,0) 
86,28 ± 2,72* 
(75,0; 95,0) 
BMI, 
kg/m2 
21,29 ± 0,25 
 (20,07; 22,34) 
28,63 ± 0,72* 
(26,24; 29,67) 
Waist girth, 
cm 
71,68 ± 0,92 
(67,0; 75,0) 
87,44 ± 2,0* 
 (80,0; 95,0) 
Hip girth,  
cm 
96,76 ± 0,69 
(94,0; 99,0) 
111,0 ± 1,79*  
(104,0; 116,5) 
Ratio between of the waist girth and hip 
girth  
0,73 ± 0,02  
(0,70; 0,78) 
0,79 ± 0,02 
 (0,75; 0,85) 
Note: hereinafter in the tables * - р<0,05 compared with the people with the normal weight. 
To evaluate the relative advantage in deposition of 
the abdominal adipose tissue we measured the waist 
girth. The average value of WG in people with the over-
weight exceeded the value of the control group by 21,9%, 
and the value of HG exceeded by 14,2% (p<0,05).  
The study of the lipid metabolism indicators showed 
no significant alteration of the indicators of CL, TG, LDL 
CL, HDL CL levels (Table 2).  
Table 2  
Lipid and carbohydrate metabolism indices in people from the surveyed groups  (М±m, lower and upper quartiles)  
 
Parameters 
People with the  
normal weight 
n=41 
People with the overweight 
 n=27 
CL,  
mmol/l  
3,46 ± 0,09  
(3,1; 3,8) 
3,65 ± 0,13  
(3,2;4,1) 
TG,  
mmol/l  
0,59 ± 0,03  
(0,5; 0,7) 
0,63 ± 0,05 
(0,4;0,7) 
LDL,  
g/l  
1,31 ± 0,04 
(1,13; 1,50) 
1,38 ± 0,05 
(1,15;1,55) 
HDL,  
mmol/l  
1,02 ± 0,04  
(0,81;1,17) 
0,90 ± 0,05 
(0,72;1,05) 
Insulin,  
mcU/ml  
10,70 ± 0,87 
 (6,30;13,70) 
15,77 ± 1,55* 
(9,30; 19,50) 
Glucose,  
mmol/l  
4,14 ± 0,11  
(3,75; 4,58) 
4,29 ± 0,07 
(4,12; 4,51) 
HOMA-IR index  2,09 ± 0,18 (1,22; 2,75) 
3,01 ± 0,30* 
(1,69; 3,80) 
 
The indicators of carbohydrate metabolism were 
characterized by the following changes. It was deter-
mined the likely increase in the insulin level by 47,38% 
and the indicator of insulin resistance index by 44,02% in 
the group of people with the overweight comparing to the 
group of people with the normal weight. The glucose 
level on an empty stomach remained in both groups 
without differences.  
The study of CP level showed its increase by 10,98% 
in people with the overweight. The level of TNF-α re-
mained unchanged (Table 3). The comparison of values 
of neuropeptide indicators in people with the normal 
weight and the overweight determined an increase of 
AgRP by 62,72% (p<0,05). CART level tended to de-
crease, but the likely differences between the two groups 
were not found (Table 3).  
                                                                 Проблеми екології та медицини 
 51
Table 3  
Indices of inflammatory markers and neuropeptides  in people from the surveyed groups (М±m, lower and upper quartiles)  
Parameters People with the normal weight n=41 
People with the overweight 
 n=27 
CP, 
mg/l 
217,67 ± 2,33 
(213,50;220,50) 
241,58 ± 7,97* 
(210,0; 267,70) 
TNF-α, 
pg/ml 
11,26 ± 1,00 
(7,50; 12,20) 
10,84 ± 0,88 
(7,60; 13,70) 
CART, 
pg/ml 
20438,11 ± 4178,66 
(389,20; 27581,0) 
11847,49 ± 4844,98 
(525,60; 6359,0) 
AgRP, 
pg/ml 
9,79 ± 1,22 
(3,50; 13,30) 
15,93 ± 2,29* 
(7,50; 24,0) 
 
In order to establish the relationship between the 
studied parameters we made a correlation analysis.  
We observed the positive correlation of a moderate 
intensity between the levels of HDL and LDL (r = 0,32, 
p<0,05) in persons with the overweight, and the correla-
tion of a very slight intensity between HDL and TG levels 
(r = 0,16, p<0,05).  
We established the relationships of an insulin level 
and the indicators of lipid metabolism. In the main group, 
we observed the positive relationships of a very slight in-
tensity between the insulin level and LDL level (r = 
0,0985, p<0,05), the level of glucose and insulin level (r = 
0,058, p<0,05), and the negative relationships between 
the insulin level and CL level (r = -0,0687, p<0,05), the 
level of insulin and triglyceride level (r = -0,062, p<0,05). 
It was also found a slight positive correlation between the 
glucose level and CL level  (r = 0,275, p<0,05), and a 
very slight correlation between the level of glucose and 
TNF-α level (r = 0,113, p<0,05) in people of the main 
group.  
We defined a very slight positive relationship between 
the indicators of glucose level and the levels of TNF-α (r 
= 0,11, p<0,05), insulin (r = 0,14,  p<0,05), and CL (r = 
0,033 p<0,05), accordingly, in people with the over-
weight. During the correlation analysis, we revealed also 
a very slight positive relationship between CL level and 
TNF-α level (r = 0,033, p<0,05), and the CP and LDL lev-
els (r = 0,131, p<0,05) in people with the overweight.  
We identified the positive correlation of slight intensity 
between the levels of insulin and TG (r = 0,198, p<0,05), 
a very slight relationships between the insulin level and 
CL level (r = 0,003, p<0,05), and the levels of glucose 
and insulin (r = 0,04, p<0,05), as well as the negative re-
lationship between the insulin level and LDL level (r = -
0,094, p<0,05) in the control group.  
Investigating the people from the control group, we 
found a slight positive correlation between the levels of 
HDL and LDL (r = 0,084, p<0,05), HDL and CL (r = 0,04, 
p<0,05), HDL and glucose (r = 0,057, p<0,05), we also 
defined a slight positive correlation between the indica-
tors of the glucose level and CL (r = 0,24, p<0,05), TG (r 
= 0,27, p <0,05), LDL (r = 0,218, p<0,05) levels, respec-
tively, and a very slight relationship between the levels of 
glucose and CP (r = 0,148, p<0,05).  
The representatives of the control group revealed a 
very slight positive relationship between the level of TNF-
α and LDL (r = 0,114, p<0,05) and CP (r = 0,0529, 
p<0,05) levels, respectively. We noticed the likely positive 
correlations of moderate intensity between the level of 
AgRP neuropeptide level and insulin level (r = 0,317, 
p<0,05) in people from the main group and the levels of 
 CART neuropeptide and insulin (r = 0,418, p<0,05) in the 
control group.  
In general, we surveyed the young people aged 18-25 
years. The people from the main group had the signifi-
cantly higher body weight, body mass index, waist girth 
and hip girth. According to the WHO classification, a per-
son with a BMI between 25,0 and 29,99 has a overweight 
that is classified as a pre-obesity [22].  
According to the modern views, the leading pathoge-
netic mechanisms of obesity are reduced to a violation of 
the energy balance [13]. Energy intake from the food ex-
ceeds its exes, resulting the energy excess accumulates 
in the body and connects to the reaction of triglyceride 
synthesis with their reinforced deposition in the adipose 
depot [20]. The violation of a diet balance and, the most 
important, the chronic hypodynamia and significant re-
duction in physical activity contributes to the accumula-
tion of triglycerides in the adipose tissue. Sedentary life-
style, lack of physical activity and exercises reduce the 
energy consumption that in combination with the ex-
ceeded energy intake play a major role in causing the 
overweight due to the fat deposits such as the subcuta-
neous fat, abdominal fat, and fat of internal organs. The 
imbalance between the energy intake from the food and 
its consumption for energy needs has a prime importance 
in almost 90% of obesity cases [12]. Usually, the physical 
activity significantly reduces in women and men with age, 
while the energy value of the food remains still prelimi-
nary, creating undesirable metabolic disorders.  
It is known that people with the overweight and obe-
sity (BMI 25-30) have an increased risk of diabetes, car-
diovascular disease, and hypertension [8, 23]. 
We have identified the credibly increased indicators of 
waist girth in people with the overweight up to 87,44 ± 2,0 
cm on average. At the same time according to the current 
diagnostic criteria of metabolic syndrome and risk of de-
velopment of cardiovascular disease, the maximum al-
lowable rates of waist girth is ≥94 cm for men and ≥80 cm 
for women [9]. That indicates the threatening condition in 
surveyed persons regarding the overweight and further 
development of the metabolic syndrome.  
During our research we found that despite the prob-
able increase in body weight and BMI, the lipid metabo-
lism indicators in the people of both groups did not differ, 
but we got the data about the credible increase of the in-
sulin level and HOMA-IR index, which calculation is the 
most effective method of assessment of insulin resis-
tance in patients with the overweight.  
Excess of coming energy contributes to the develop-
ment of hyperinsulinemia and insulin resistance. Even a 
small increase of insulin level in plasma can cause a se-
vere insulin resistance. Insulin resistance is associated 
with an increased risk of diabetes and cardiovascular 
diseases, and it is an important component of the patho-
physiological mechanisms of obesity connection with 
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these types of diseases, including the metabolic syn-
drome.  
According to our data, on the background of the high in-
sulin level, the indices of glucose level hardly differed in 
people from the main and control groups. Similar data on 
the unmodified glucose level in patients with the arterial hy-
pertension with the obesity was received by Goptsyi O.V. 
[1].  
On the other hand, one of the key points of intracellular 
signaling responsible for the development of insulin resis-
tance is NF-κB signaling path [5]. The nuclear factor of κB 
transcription, as a major intracellular regulator of inflamma-
tory reactions, changes the gene expression of cytokines 
and adhesion molecules that leads to an increase and 
spreading of inflammation to other cells, thus contributing to 
the process of inflammation. Based on the studies, we de-
veloped the concept of permanent activation of NF-κB as a 
possible typical pathological process, when this factor is in-
volved in the formation of "vicious circle": insulin resistance - 
inflammation – atherosclerosis [2].  
In turn, the majority of the anti-inflammatory cytokines 
increase the expression of NF-κB and cause a reciprocal 
activation of their synthesis [7]. 
The relation between the indicators of lipid, carbohy-
drate metabolism and the markers of inflammation was 
found, in particular, the leading pathogenetic role of 
chronic systemic inflammation in the development of in-
sulin resistance, metabolic syndrome, and type 2 diabe-
tes was confirmed [21].  
One of the most sensitive markers of systemic in-
flammation may be CP [4], whose level was credibly 
higher in people with the overweight. In our opinion, the 
likely increase of CP level is the first sign of the formation 
of chronic inflammation processes in people with the 
overweight. At the same time, other pro-inflammatory cy-
tokine - TNF-α - remained unchanged.  
Obviously, our data shows no significant alteration of 
TNF-α level that may be due to the not enough weight gain 
in respondents, but it could also be because the gradual 
weight gain will lead to changes in the level of TNF-α after 
CP. This is confirmed by the presence of large numbers in 
the vast majority of slight and very slight connections be-
tween the lipid, carbohydrate metabolism and markers of 
systemic inflammation, including CP and TNF-α.  
Similar results were obtained by Chukaeva I.I. and 
colleagues, according to which a positive correlation of 
medium strength between the level of stimulated glucose 
with TNF-α (r = 0,69, p <0,05) and interleukin-4 (r = 0,64, 
p<0,05) was found [6]. The positive connection of moder-
ate intensity between the level of glucose and TNF-α (r = 
0,31, p<0,05), the strong connection between the levels 
of insulin and TNF-α (r = 0,91, p <0,05) were found in 
people with the arterial hypertension and obesity [1].  
The results of the experimental studies have provided 
the possibility to suggest that the signaling module of nu-
clear factor of κB-IKKβ/NF-κB transcription mediates the 
fundamental connection between the excessive intake of 
nutritive substances and the dysfunction of the hypotha-
lamic signaling [29].  
It is known, the hypothalamus plays a central role in 
the regulation of appetite and energy expenditure. In par-
ticular, the mediobasal hypothalamic arcuate nucleus, 
which is critical for the regulation of appetite, food intake 
and energy homeostasis, contains two types of neuron 
populations with opposite effects on food consumption 
[18]. The balance between the activity of these neuronal 
areas is critical for the regulation of body weight.  
The medial group of NPY/AgRP neurons expresses the 
orexigenic peptides, neuropeptide-Y (NPY) and AgRP, 
which cause an increase in food consumption [25].  
Agouti-related protein (Agouti-Related Protein — AgRP) 
holds a central place in the energy metabolism. It impacts 
the modulation of efficiency of signaling function of hypotha-
lamic receptors to the type 3 and 4 melanocortin (Melano-
cortin Receptors - McR), resulting the appetite stimulates 
and the energy consumption decreases [15].  
Anorexigenic lateral neurons express alpha-
melanocyte-stimulating hormone (α-MSH), which is a 
derivate of proopiomelanocortin (POMC) and cocaine 
and amphetamine-regulated transcript (Cocaine and am-
phetamine- regulated transcript - CART). CART is an 
anorexigenic peptide that plays a central role in the regu-
lation of feeding behavior, level of appetite, thermogene-
sis and is a major messenger of nociceptive system [10].  
The central control of an energy balance depends on 
the ability of POMC or AgRP hypothalamic neurons to 
sense and to respond to the changes in the peripheral 
energy depots.  
A high density of receptors to the peripheral hor-
mones expressed in the POMC/CART and NPY/AgRP 
neurons, including insulin and leptin. Insulin informs the 
central nervous system on the state of saturation and 
obesity, and together with the leptin mediate the long-
term regulation of energy balance. Available data sug-
gest that insulin and leptin act for the brain as negative 
feedback signals of obesity [17]. The central action of in-
sulin contributes to anorexia by inhibiting the expression 
of NPY and stimulating the expression of POMC [19]. 
Both, insulin and leptin activate POMC neurons, but they 
regulate AgRP differently, when leptin inhibits, insulin 
stimulates its synthesis [24].  
According to our data, exactly in people with the 
overweight there was an increase in insulin level and 
level of AgRP neuropeptide comparing to a group of 
people with the normal weight by 62,72%, the indices of 
CART level were higher in the control group. It should be 
noted a clear correlation of indicators of neuropeptide 
and insulin levels. Moreover, in people with the over-
weight was observed a credibly positive correlation of 
moderate intensity between the level of orexigenic AgRP 
neuropeptide and insulin (r = 0,317, p<0,05), while in 
people with the normal weight from the control group a 
correlation between the levels of anorexigenic CART 
neuropeptide and insulin (r = 0,418, p<0,05) was found.  
It is confirmed at present that the energy excess in-
take in the human body is the result of violation of eating 
behavior. The violation of eating behavior accompanied 
by an increased and unbalanced supply of nutrients 
along with the hypodynamia become the major factors 
that contribute to the increase of energy storage. Thus, 
the concept of energy imbalance, along with the alimen-
tary disorders includes the physical activity decrease, 
when the low physical inactivity creates an energy ex-
cess and increases the weight gain. In turn, as a result, 
the formation of two interrelated parts - the formation of 
insulin resistance and chronic inflammation, which clearly 
correlates with the beginning of failure in hypothalamic 
signaling observed.  
We believe that due to the intake of moderate inten-
sity of nutrients, the insulin level is sufficient to inhibit the 
selection of orexigenic neuropeptides according to the 
feedback principle, delivering a saturation signal to the 
central structure. But under the conditions of excess up-
take of nutrients, due to the formation of hyperinsulinemia 
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and insulin resistance, exactly the insulin, not leptin, con-
tributes to an increased release of AgRP neuropeptide 
and early formation of pathological range. Given that, the 
arcuate nuclei neurons of the hypothalamus expressing 
the AgRP neuropeptide, stimulate the food intake, provid-
ing an anabolic effect, its increased level promotes the 
further weight gain.  
The changes on the level of central regulation mecha-
nisms of energy homeostasis support determined by the in-
crease of orexigenic AgRP neuropeptide production, the 
gradual formation of insulin resistance and chronic systemic 
inflammation occurring in the young people with the over-
weight, indicate the beginning of the formation of pathoge-
netic basis of metabolic syndrom  in our view. 
Given the young age of the respondents and their 
lack of acute and chronic inflammatory diseases at the 
moment, such condition already requires a mandatory 
physiological correction by the formation of a healthy life-
style, especially by the implementing of a balanced diet 
with a reduced calories and optimal physical activity.  
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